The key components target fat cells and assist in metabolism, making them popular additions to medical weight loss programs and comprehensive treatment plans
A 1,000-microgram tablet would be expected to result in a 10 to 20-microgram dose
Legal and Safety Information: All UK-Peptides products, including AOD 9604, are sold exclusively for research
Once-weekly dosing: Tirzepatide is administered once a week by subcutaneous injection, which offers convenience and may improve treatment adherence
Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption
